The Beta-Amyloid Protein of Alzheimer's Disease: Communication Breakdown by Modifying the Neuronal Cytoskeleton

Alzheimer's disease (AD) is one of the most prevalent severe neurological disorders afflicting our aged population. Cognitive decline, a major symptom exhibited by AD patients, is associated with neuritic dystrophy, a degenerative growth state of neurites. The molecular mechanisms governing neuritic dystrophy remain unclear. Mounting evidence indicates that the AD-causative agent, β-amyloid protein (Aβ), induces neuritic dystrophy. Indeed, neuritic dystrophy is commonly found decorating Aβ-rich amyloid plaques (APs) in the AD brain. Furthermore, disruption and degeneration of the neuronal microtubule system in neurons forming dystrophic neurites may occur as a consequence of Aβ-mediated downstream signaling. This review defines potential molecular pathways, which may be modulated subsequent to Aβ-dependent interactions with the neuronal membrane as a consequence of increasing amyloid burden in the brain.

[1]  A. Delacourte,et al.  Association study of three polymorphisms of kinesin light-chain 1 gene with Alzheimer's disease , 2004, Neuroscience Letters.

[2]  N. Ip,et al.  Cdk5: a multifaceted kinase in neurodegenerative diseases. , 2012, Trends in cell biology.

[3]  D. M. Ando,et al.  No difference in kinetics of tau or histone phosphorylation by CDK5/p25 versus CDK5/p35 in vitro , 2010, Proceedings of the National Academy of Sciences.

[4]  Ed X. Wu,et al.  Early detection of neurodegeneration in brain ischemia by manganese-enhanced MRI , 2008, 2008 30th Annual International Conference of the IEEE Engineering in Medicine and Biology Society.

[5]  G. Cole,et al.  Synaptic changes in Alzheimer's disease: increased amyloid-beta and gliosis in surviving terminals is accompanied by decreased PSD-95 fluorescence. , 2004, The American journal of pathology.

[6]  D. Small,et al.  The beta-amyloid protein of Alzheimer's disease increases neuronal CRMP-2 phosphorylation by a Rho-GTP mechanism. , 2008, Brain : a journal of neurology.

[7]  T. Suuronen,et al.  ROCK, PAK, and Toll of synapses in Alzheimer's disease. , 2008, Biochemical and biophysical research communications.

[8]  I. Grundke‐Iqbal,et al.  Cytosolic abnormally hyperphosphorylated tau but not paired helical filaments sequester normal MAPs and inhibit microtubule assembly. , 2008, Journal of Alzheimer's disease : JAD.

[9]  Shanshan Ma,et al.  GSK‐3α/β‐mediated phosphorylation of CRMP‐2 regulates activity‐dependent dendritic growth , 2013, Journal of neurochemistry.

[10]  L. Tsai,et al.  Mice Lacking p35, a Neuronal Specific Activator of Cdk5, Display Cortical Lamination Defects, Seizures, and Adult Lethality , 1997, Neuron.

[11]  Y. Goshima,et al.  Phosphorylation of Collapsin Response Mediator Protein-2 by Rho-kinase , 2000, The Journal of Biological Chemistry.

[12]  B. Lu,et al.  National Institutes of Health , 2020, The Grants Register 2021.

[13]  D. Selkoe,et al.  Cell-surface beta-amyloid precursor protein stimulates neurite outgrowth of hippocampal neurons in an isoform-dependent manner , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[14]  P. Cohen,et al.  GSK3 takes centre stage more than 20 years after its discovery. , 2001, The Biochemical journal.

[15]  D. Holtzman,et al.  Deciphering Alzheimer disease. , 2012, Cold Spring Harbor perspectives in medicine.

[16]  F. LaFerla,et al.  Amyloid-beta peptides stimulate the expression of the p75(NTR) neurotrophin receptor in SHSY5Y human neuroblastoma cells and AD transgenic mice. , 2010, Journal of Alzheimer's disease : JAD.

[17]  B. Anderton,et al.  Beta amyloid precursor protein mediates neuronal cell‐cell and cell‐surface adhesion , 1991, Journal of neuroscience research.

[18]  T. Arendt,et al.  Phosphorylation of Tau, Aβ-Formation, and Apoptosis After In Vivo Inhibition of PP-1 and PP-2A , 1998, Neurobiology of Aging.

[19]  K. Hensley,et al.  Collapsin Response Mediator Protein-2: An Emerging Pathologic Feature and Therapeutic Target for Neurodisease Indications , 2011, Molecular Neurobiology.

[20]  R. Maccioni,et al.  The revitalized tau hypothesis on Alzheimer's disease. , 2010, Archives of medical research.

[21]  T. Kanno,et al.  Stimulation-Dependent Intraspinal Microtubules and Synaptic Failure in Alzheimer's Disease: A Review , 2012, International journal of Alzheimer's disease.

[22]  Dan Zhang,et al.  The early events of Alzheimer's disease pathology: from mitochondrial dysfunction to BDNF axonal transport deficits , 2012, Neurobiology of Aging.

[23]  J. Bamburg,et al.  Activated Actin-Depolymerizing Factor/Cofilin Sequesters Phosphorylated Microtubule-Associated Protein during the Assembly of Alzheimer-Like Neuritic Cytoskeletal Striations , 2009, The Journal of Neuroscience.

[24]  J. Fiala.  Mechanisms of amyloid plaque pathogenesis , 2007, Acta Neuropathologica.

[25]  G. Stokin,et al.  Imaging amyloid precursor protein in vivo: an axonal transport assay. , 2012, Methods in molecular biology.

[26]  Jürgen Götz,et al.  Parkinsonism and impaired axonal transport in a mouse model of frontotemporal dementia , 2008, Proceedings of the National Academy of Sciences.

[27]  K. Kaibuchi,et al.  CRMP-2 induces axons in cultured hippocampal neurons , 2001, Nature Neuroscience.

[28]  L. Goldstein,et al.  Axonal Transport of Amyloid Precursor Protein Is Mediated by Direct Binding to the Kinesin Light Chain Subunit of Kinesin-I , 2000, Neuron.

[29]  E. Mandelkow,et al.  Tau protein and tau aggregation inhibitors , 2010, Neuropharmacology.

[30]  D. Small,et al.  A heparin-binding domain in the amyloid protein precursor of Alzheimer's disease is involved in the regulation of neurite outgrowth , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[31]  Cornelia M. Wilson,et al.  Tau protein phosphatases in Alzheimer's disease: The leading role of PP2A , 2013, Ageing Research Reviews.

[32]  Angus C. Nairn,et al.  Protein phosphatases and Alzheimer's disease. , 2012, Progress in molecular biology and translational science.

[33]  A. Vortmeyer,et al.  Alzheimer Amyloid-β Oligomer Bound to Post-Synaptic Prion Protein Activates Fyn to Impair Neurons , 2012, Nature Neuroscience.

[34]  P. Cras,et al.  Senile plaque neurites in Alzheimer disease accumulate amyloid precursor protein. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[35]  T. Oltersdorf,et al.  Cleavage of amyloid beta peptide during constitutive processing of its precursor. , 1990, Science.

[36]  E. Masliah,et al.  APP transgenic modeling of Alzheimer’s disease: mechanisms of neurodegeneration and aberrant neurogenesis , 2009, Brain Structure and Function.

[37]  J. Honnorat,et al.  Involvement of collapsin response mediator proteins in the neurite extension induced by neurotrophins in dorsal root ganglion neurons , 2004, Molecular and Cellular Neuroscience.

[38]  G. Bokoch,et al.  Membrane targeting of p21‐activated kinase 1 (PAK1) induces neurite outgrowth from PC12 cells , 1998, The EMBO journal.

[39]  Veeranna,et al.  Targeted disruption of the cyclin-dependent kinase 5 gene results in abnormal corticogenesis, neuronal pathology and perinatal death. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[40]  M. Vila,et al.  Series Introduction: Neurodegeneration: What is it and where are we? , 2003 .

[41]  K. Kaibuchi,et al.  CRMP-2 regulates polarized Numb-mediated endocytosis for axon growth , 2003, Nature Cell Biology.

[42]  T. Bottiglieri,et al.  Folate Deficiency Induces In Vitro and Mouse Brain Region-Specific Downregulation of Leucine Carboxyl Methyltransferase-1 and Protein Phosphatase 2A Bα Subunit Expression That Correlate with Enhanced Tau Phosphorylation , 2008, The Journal of Neuroscience.

[43]  Fei Liu,et al.  Contributions of protein phosphatases PP1, PP2A, PP2B and PP5 to the regulation of tau phosphorylation , 2005, The European journal of neuroscience.

[44]  K. Kaibuchi,et al.  GSK-3β Regulates Phosphorylation of CRMP-2 and Neuronal Polarity , 2005, Cell.

[45]  G. L. Li,et al.  Accumulation of β-amyloid precursor protein and ubiquitin in axons after spinal cord trauma in humans: immunohistochemical observations on autopsy material , 1996, Acta Neuropathologica.

[46]  R. Terry.  The cytoskeleton in Alzheimer disease. , 1998, Journal of neural transmission. Supplementum.

[47]  Gaudenz Danuser,et al.  Molecular motor function in axonal transport in vivo probed by genetic and computational analysis in Drosophila , 2012, Molecular biology of the cell.

[48]  N. Hirokawa,et al.  Tau Proteins: the Molecular Structure and Mode of Binding on Microtubules Materials and Methods Isolation of Tau , 1988 .

[49]  C. Arias,et al.  GSK3 Function in the Brain during Development, Neuronal Plasticity, and Neurodegeneration , 2011, International journal of Alzheimer's disease.

[50]  H. Tanila,et al.  Phosphorylated PP2A (tyrosine 307) is associated with Alzheimer neurofibrillary pathology , 2007, Journal of cellular and molecular medicine.

[51]  Jianhua Shi,et al.  PP2A regulates tau phosphorylation directly and also indirectly via activating GSK-3beta. , 2010, Journal of Alzheimer's disease : JAD.

[52]  A. Verkhratsky,et al.  Collapsin response mediator protein‐2 hyperphosphorylation is an early event in Alzheimer’s disease progression , 2007, Journal of neurochemistry.

[53]  K. Kaibuchi,et al.  Tubulin and CRMP‐2 complex is transported via Kinesin‐1 , 2005, Journal of neurochemistry.

[54]  Jian-Zhi Wang,et al.  Protein phosphatase 2A in Alzheimer's disease. , 2009, Pathophysiology : the official journal of the International Society for Pathophysiology.

[55]  U. Armato,et al.  The killing of neurons by beta-amyloid peptides, prions, and pro-inflammatory cytokines. , 2006, Italian journal of anatomy and embryology = Archivio italiano di anatomia ed embriologia.

[56]  G. Perry,et al.  Striation is the characteristic neuritic abnormality in Alzheimer disease , 1998, Brain Research.

[57]  I. Grundke‐Iqbal,et al.  Up-regulation of inhibitors of protein phosphatase-2A in Alzheimer's disease. , 2005, The American journal of pathology.

[58]  R. Nitsch,et al.  Reduced protein phosphatase 2A activity induces hyperphosphorylation and altered compartmentalization of tau in transgenic mice. , 2001, The Journal of biological chemistry.

[59]  C. W. Scott,et al.  Tau protein induces bundling of microtubules in vitro: Comparison of different tau isoforms and a tau protein fragment , 1992, Journal of neuroscience research.

[60]  P. Greengard,et al.  Neuron‐Specific Phosphorylation of Alzheimer's β‐Amyloid Precursor Protein by Cyclin‐Dependent Kinase 5 , 2000, Journal of neurochemistry.

[61]  H. Querfurth,et al.  Cross‐functional E3 ligases Parkin and C‐terminus Hsp70‐interacting protein in neurodegenerative disorders , 2012, Journal of neurochemistry.

[62]  S. Pimplikar,et al.  Activation of GSK-3 and phosphorylation of CRMP2 in transgenic mice expressing APP intracellular domain , 2005, The Journal of cell biology.

[63]  F. Terro,et al.  Post-translational modifications of tau protein: Implications for Alzheimer's disease , 2011, Neurochemistry International.

[64]  T. Takenawa,et al.  CRMP-2 Is Involved in Kinesin-1-Dependent Transport of the Sra-1/WAVE1 Complex and Axon Formation , 2005, Molecular and Cellular Biology.

[65]  E. Masliah,et al.  Peptides containing the RERMS sequence of amyloid beta/A4 protein precursor bind cell surface and promote neurite extension , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[66]  吉村 武.  GSK-3β regulates phosphorylation of CRMP-2 and neuronal polarity , 2005 .

[67]  J. Trojanowski,et al.  The characterization of microtubule-stabilizing drugs as possible therapeutic agents for Alzheimer's disease and related tauopathies. , 2011, Pharmacological research.

[68]  L. Goldstein.  Axonal Transport and Alzheimer’s Disease , 2009 .

[69]  I. Grundke‐Iqbal,et al.  Alzheimer abnormally phosphorylated tau is more hyperphosphorylated than the fetal tau and causes the disruption of microtubules , 1995, Neurobiology of Aging.

[70]  K. Kaibuchi,et al.  Role of CRMP-2 in neuronal polarity. , 2004, Journal of neurobiology.

[71]  C. Masters,et al.  The amyloid protein precursor of Alzheimer's disease is a mediator of the effects of nerve growth factor on neurite outgrowth , 1992, Neuron.

[72]  K. Lu,et al.  Relative Resistance of Cdk5-phosphorylated CRMP2 to Dephosphorylation* , 2008, Journal of Biological Chemistry.

[73]  Richard G. W. Anderson,et al.  Integrins Regulate Rac Targeting by Internalization of Membrane Domains , 2004, Science.

[74]  C. Bandtlow,et al.  Nogo-A and Myelin-Associated Glycoprotein Mediate Neurite Growth Inhibition by Antagonistic Regulation of RhoA and Rac1 , 2002, The Journal of Neuroscience.

[75]  S. Strittmatter,et al.  Brain CRMP Forms Heterotetramers Similar to Liver Dihydropyrimidinase , 1997, Journal of neurochemistry.

[76]  M. Nonaka,et al.  A novel gene family defined by human dihydropyrimidinase and three related proteins with differential tissue distribution. , 1996, Gene.

[77]  C. Masters,et al.  The Role of Heparan Sulfate Proteoglycans in the Pathogenesis of Alzheimer's Disease a , 1996, Annals of the New York Academy of Sciences.

[78]  D. Selkoe.  Alzheimer's disease. , 2011, Cold Spring Harbor perspectives in biology.

[79]  E. Masliah,et al.  Axonopathy and Transport Deficits Early in the Pathogenesis of Alzheimer's Disease , 2005, Science.

[80]  C. Jack,et al.  Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade , 2010, The Lancet Neurology.

[81]  R. Wait,et al.  A Collapsin Response Mediator Protein 2 Isoform Controls Myosin II-Mediated Cell Migration and Matrix Assembly by Trapping ROCK II , 2012, Molecular and Cellular Biology.

[82]  Carole J Proctor,et al.  GSK3 and p53 - is there a link in Alzheimer's disease? , 2010, Molecular Neurodegeneration.

[83]  B. S. Manjunath,et al.  Silencing of CDK5 Reduces Neurofibrillary Tangles in Transgenic Alzheimer's Mice , 2010, The Journal of Neuroscience.

[84]  J. Wegiel,et al.  Phosphorylation of Microtubule-associated Protein Tau Is Regulated by Protein Phosphatase 2A in Mammalian Brain , 2000, The Journal of Biological Chemistry.

[85]  G. Cole,et al.  p21-activated Kinase-aberrant Activation and Translocation in Alzheimer Disease Pathogenesis* , 2008, Journal of Biological Chemistry.

[86]  Shaomin Li,et al.  Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory , 2008, Nature Medicine.

[87]  A. Cadete-Leite,et al.  A quantitative study of frontal cortex dendritic microtubules in patients with Alzheimer's disease , 1987, Brain Research.

[88]  T. Arendt,et al.  Modulation of APP processing and secretion by okadaic acid in primary guinea pig neurons , 2000, Journal of Neural Transmission.

[89]  J. Trojanowski,et al.  PP2A mRNA Expression Is Quantitatively Decreased in Alzheimer's Disease Hippocampus , 2001, Experimental Neurology.

[90]  S. Speciale,et al.  Altered Expression Levels of the Protein Phosphatase 2A ABαC Enzyme Are Associated with Alzheimer Disease Pathology , 2004, Journal of neuropathology and experimental neurology.

[91]  G. Johnson,et al.  Cyclin‐dependent kinase‐5 in neurodegeneration , 2004, Journal of neurochemistry.

[92]  David McCleary,et al.  Kinesin-1 transport reductions enhance human tau hyperphosphorylation, aggregation and neurodegeneration in animal models of tauopathies. , 2010, Human molecular genetics.

[93]  M. Ciotti,et al.  Endogenous Aβ causes cell death via early tau hyperphosphorylation , 2011, Neurobiology of Aging.

[94]  P. Greengard,et al.  Regulation of NMDA receptor trafficking by amyloid-β , 2005, Nature Neuroscience.

[95]  L. Goldstein,et al.  Axonal transport and Alzheimer's disease. , 2006, Annual review of biochemistry.

[96]  Y. Kirino,et al.  Phosphorylation-dependent Regulation of the Interaction of Amyloid Precursor Protein with Fe65 Affects the Production of β-Amyloid* , 2001, The Journal of Biological Chemistry.

[97]  L. Goldstein,et al.  Enhanced β-secretase processing alters APP axonal transport and leads to axonal defects. , 2012, Human molecular genetics.

[98]  S. Strittmatter,et al.  A Family of Rat CRMP Genes Is Differentially Expressed in the Nervous System , 1996, The Journal of Neuroscience.

[99]  Miles C. Miller,et al.  RAGE, LRP-1, and amyloid-beta protein in Alzheimer’s disease , 2006, Acta Neuropathologica.

[100]  P. Gallagher,et al.  Phosphorylation of Myosin Light Chain Kinase by p21-activated Kinase PAK2* , 2000, The Journal of Biological Chemistry.

[101]  L. Goldstein,et al.  Subpixel colocalization reveals amyloid precursor protein-dependent kinesin-1 and dynein association with axonal vesicles , 2012, Proceedings of the National Academy of Sciences.

[102]  J. Niu,et al.  LIM Kinase 1 Coordinates Microtubule Stability and Actin Polymerization in Human Endothelial Cells* , 2005, Journal of Biological Chemistry.

[103]  C. Sutherland,et al.  Increased CRMP2 phosphorylation is observed in Alzheimer's disease; does this tell us anything about disease development? , 2009, Current Alzheimer research.

[104]  J. Settleman,et al.  Modulation of Rho GTPase Signaling Regulates a Switch between Adipogenesis and Myogenesis , 2003, Cell.

[105]  Kang Hu,et al.  High-Level Neuronal Expression of Aβ1–42 in Wild-Type Human Amyloid Protein Precursor Transgenic Mice: Synaptotoxicity without Plaque Formation , 2000, The Journal of Neuroscience.

[106]  K. Nakao,et al.  ROCK‐I and ROCK‐II, two isoforms of Rho‐associated coiled‐coil forming protein serine/threonine kinase in mice , 1996, FEBS letters.

[107]  Paul Greengard,et al.  Inhibition of Protein Phosphatase 1 Stimulates Secretion of Alzheimer Amyloid Precursor Protein , 1995, Molecular medicine.

[108]  S. Hirai,et al.  Senile Degenerative Brain Lesions and Dementia , 1975, Journal of the American Geriatrics Society.

[109]  Z. Muresan,et al.  Neuritic Deposits of Amyloid-β Peptide in a Subpopulation of Central Nervous System-Derived Neuronal Cells , 2006, Molecular and Cellular Biology.

[110]  T. Chew,et al.  Phosphorylation of non-muscle myosin II regulatory light chain by p21-activated kinase (γ-PAK) , 1998, Journal of Muscle Research & Cell Motility.

[111]  Yigong Shi,et al.  Structure of a protein phosphatase 2A holoenzyme: insights into B55-mediated Tau dephosphorylation. , 2008, Molecular cell.

[112]  I. Lieberburg,et al.  Cellular mechanisms of beta-amyloid production and secretion. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[113]  Lili Wang,et al.  Interplay between Cyclin-Dependent Kinase 5 and Glycogen Synthase Kinase 3β Mediated by Neuregulin Signaling Leads to Differential Effects on Tau Phosphorylation and Amyloid Precursor Protein Processing , 2008, The Journal of Neuroscience.

[114]  P. Reddy,et al.  Aging and amyloid beta-induced oxidative DNA damage and mitochondrial dysfunction in Alzheimer's disease: implications for early intervention and therapeutics. , 2011, Biochimica et biophysica acta.

[115]  C Van Hoof,et al.  Purification of porcine brain protein phosphatase 2A leucine carboxyl methyltransferase and cloning of the human homologue. , 1999, Biochemistry.

[116]  K. Mikoshiba,et al.  Semaphorin3A signalling is mediated via sequential Cdk5 and GSK3β phosphorylation of CRMP2: implication of common phosphorylating mechanism underlying axon guidance and Alzheimer's disease , 2005, Genes to cells : devoted to molecular & cellular mechanisms.

[117]  G. Gallo.  Myosin II activity is required for severing-induced axon retraction in vitro , 2004, Experimental Neurology.

[118]  R. Maccioni,et al.  Mild cognitive impairment and Alzheimer patients display different levels of redox-active CSF iron. , 2008, Journal of Alzheimer's disease : JAD.

[119]  B. Teter,et al.  Role of p21-activated kinase pathway defects in the cognitive deficits of Alzheimer disease , 2006, Nature Neuroscience.

[120]  L. Mucke,et al.  Reducing Endogenous Tau Ameliorates Amyloid ß-Induced Deficits in an Alzheimer's Disease Mouse Model , 2007, Science.

[121]  D. Bredesen,et al.  Signal transduction in Alzheimer disease: p21‐activated kinase signaling requires C‐terminal cleavage of APP at Asp664 , 2008, Journal of neurochemistry.

[122]  R. Maccioni,et al.  Oxidative stress promotes tau dephosphorylation in neuronal cells: the roles of cdk5 and PP1. , 2004, Free radical biology & medicine.

[123]  W. Snider,et al.  Functions of GSK-3 Signaling in Development of the Nervous System , 2011, Front. Mol. Neurosci..

[124]  A. Irving,et al.  GSK-3 Phosphorylation of the Alzheimer Epitope within Collapsin Response Mediator Proteins Regulates Axon Elongation in Primary Neurons* , 2004, Journal of Biological Chemistry.

[125]  A. Nógrádi,et al.  Severely dystrophic axons at amyloid plaques remain continuous and connected to viable cell bodies. , 2009, Brain : a journal of neurology.

[126]  Tsuyoshi Morita,et al.  Specification of Neuronal Polarity Regulated by Local Translation of CRMP2 and Tau via the mTOR-p70S6K Pathway* , 2009, The Journal of Biological Chemistry.

[127]  D. Selkoe,et al.  X-ray diffraction from intraneuronal paired helical filaments and extraneuronal amyloid fibers in Alzheimer disease indicates cross-beta conformation. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[128]  S. Weggen,et al.  Inhibitors of Rho‐kinase modulate amyloid‐β (Aβ) secretion but lack selectivity for Aβ42 , 2006 .

[129]  A. Prochiantz,et al.  Downregulation of amyloid precursor protein inhibits neurite outgrowth in vitro , 1995, The Journal of cell biology.

[130]  R. Mayeux,et al.  Plasma Aβ and PET PiB binding are inversely related in mild cognitive impairment , 2011, Neurology.

[131]  Y. Imai,et al.  Expression, purification, and neurotrophic activity of amyloid precursor protein-secreted forms produced by yeast. , 1995, Biochemical and biophysical research communications.

[132]  K. Kaibuchi,et al.  CRMP-2 binds to tubulin heterodimers to promote microtubule assembly , 2002, Nature Cell Biology.

[133]  C. Behl,et al.  Hydrogen peroxide mediates amyloid β protein toxicity , 1994, Cell.

[134]  R. Maccioni,et al.  Insulin resistance and Alzheimer's disease: molecular links & clinical implications. , 2008, Current Alzheimer research.

[135]  J. Kelly,et al.  Identification of okadaic acid-induced phosphorylation events by a mass spectrometry approach. , 2006, Biochemical and biophysical research communications.

[136]  C. Masters,et al.  Secreted Glypican Binds to the Amyloid Precursor Protein of Alzheimer's Disease (APP) and Inhibits APP-induced Neurite Outgrowth* , 1996, The Journal of Biological Chemistry.

[137]  M. Brunelli,et al.  Up-regulation of kinesin light-chain 1 gene expression by acetyl-l-carnitine: Therapeutic possibility in Alzheimer's disease , 2008, Neurochemistry International.

[138]  N. Robakis,et al.  An Alternative Secretase Cleavage Produces Soluble Alzheimer Amyloid Precursor Protein Containing a Potentially Amyloidogenic Sequence , 1992, Journal of neurochemistry.

[139]  M. Staufenbiel,et al.  Phosphorylation of Actin-Depolymerizing Factor/Cofilin by LIM-Kinase Mediates Amyloid β-Induced Degeneration: A Potential Mechanism of Neuronal Dystrophy in Alzheimer's Disease , 2006, The Journal of Neuroscience.

[140]  B. Lamb,et al.  The Cleavage Products of Amyloid-β Precursor Protein Are Sorted to Distinct Carrier Vesicles That Are Independently Transported within Neurites , 2009, Journal of Neuroscience.

[141]  Gang Zhao,et al.  Ginsenoside Rd attenuates beta-amyloid-induced tau phosphorylation by altering the functional balance of glycogen synthase kinase 3beta and protein phosphatase 2A , 2013, Neurobiology of Disease.

[142]  Yoji Kawano,et al.  Phosphorylation by Rho Kinase Regulates CRMP-2 Activity in Growth Cones , 2005, Molecular and Cellular Biology.

[143]  D. Price,et al.  Evidence that beta-amyloid protein in Alzheimer's disease is not derived by normal processing. , 1990, Science.

[144]  Marek Luczkowski,et al.  Copper, zinc and iron in neurodegenerative diseases (Alzheimer's, Parkinson's and prion diseases) , 2012 .

[145]  THE ~-AMYLOID PROTEIN OF ALZHEIMER ' S DISEASE , .

[146]  L S Goldstein,et al.  Kinesin molecular motors: Transport pathways, receptors, and human disease , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[147]  R. Diaz-Arrastia,et al.  Protein Phosphatase 2A Methyltransferase Links Homocysteine Metabolism with Tau and Amyloid Precursor Protein Regulation , 2007, The Journal of Neuroscience.